SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific - Quaterly Results

08 Aug 2022 Evaluate
A decent increase of about 39.01% in the sales to Rs. 648.60 millions was observed for the quarter ended June 2022. The sales figure stood at Rs. 466.57 millions during the year-ago period.The Total Profit for the quarter ended June 2022 of Rs. 8.40 millions grew from Rs.-6.09 millionsOperating profit for the quarter ended June 2022 rose to 38.90 millions as compared to 16.02 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 648.60 466.57 39.01 648.60 466.57 39.01 2196.26 2654.57 -17.26
Other Income 58.80 57.63 2.03 58.80 57.63 2.03 276.43 199.66 38.45
PBIDT 38.90 16.02 142.82 38.90 16.02 142.82 268.93 552.56 -51.33
Interest 3.54 1.67 111.98 3.54 1.67 111.98 16.10 26.80 -39.93
PBDT 35.36 14.35 146.41 35.36 14.35 146.41 252.83 500.15 -49.45
Depreciation 23.81 23.08 3.16 23.81 23.08 3.16 95.93 91.28 5.09
PBT 11.55 -8.73 -232.30 11.55 -8.73 -232.30 156.90 408.87 -61.63
TAX 3.15 -2.64 -219.32 3.15 -2.64 -219.32 8.91 87.74 -89.84
Deferred Tax 1.05 -1.06 -199.06 1.05 -1.06 -199.06 5.20 26.89 -80.66
PAT 8.40 -6.09 -237.93 8.40 -6.09 -237.93 147.99 321.13 -53.92
Equity 498.87 496.74 0.43 498.87 496.74 0.43 496.74 496.74 0.00
PBIDTM(%) 6.00 3.43 74.67 6.00 3.43 74.67 12.24 20.82 -41.17

Viyash Scientific Share Price

208.90 0.05 (0.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×